Investor Presentaiton
8
+
IDEAYA Precision Medicine Oncology Drug Discovery Platform
Structure-Based Drug Design & Proprietary Chemical Library Enable "Hard to Drug" Targets
Structural Biology & Structure Based Drug Design
Full suite of capabilities in structural biology,
biophysics, & computational chemistry
Ligand bound co-crystal structures resolved to
enable Structure Based Drug Design for each of the
Synthetic Lethality drug-discovery programs
Multiple potential "first-in-world" co-crystal
structures resolved, including for PARG, Pol Theta
Helicase and Werner Helicase
INQUIRE™ Proprietary Chemical Library
Expert-curated HTS library to enhance hit discovery
capabilities against novel SL targets classes, such as helicases and
endonucleases
Enhances IDEAYA's SL Drug Discovery Platform and
competitive differentiation
HARMONY™ Proprietary Machine-Learning
Internal Machine-Learning engine empowers
discovery platform through effective prioritization
leading to efficient SAR cycles
IDEAVA
BIOSCIENCESView entire presentation